It has been shown that targeting DDX3X inhibits mitochondrial translation, subsequently decreasing oxidative phosphorylation (OXPHOS) and increasing ROS production, causing metabolic disturbances in cancer cells and ultimately leading to cell death. Here, DDX3X is linked to cancer.